Provided by Tiger Fintech (Singapore) Pte. Ltd.

ArTara Therapeutics, Inc.

3.50
+0.10002.94%
Post-market: 3.500.00000.00%16:07 EDT
Volume:556.42K
Turnover:1.92M
Market Cap:128.69M
PE:-1.62
High:3.55
Open:3.35
Low:3.28
Close:3.40
Loading ...
Apr 28, 2025

Major Issues Report

Form 8-K - Current report
Mar 26, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 06, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 05, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 05, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Dec 17, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Dec 11, 2024

Major Issues Report

Form 8-K - Current report
Dec 05, 2024

Major Issues Report

Form 8-K - Current report
Nov 18, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Aug 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2024

Major Issues Report

Form 8-K - Current report
Aug 06, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 10, 2024

Major Issues Report

Form 8-K - Current report
May 07, 2024

Correspondence

Form CORRESP - Correspondence
May 02, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]